Do Elevated Autoantibodies in Patients With Multiple Sclerosis Matter ?

ConclusionsAccording to our data, elevated serum autoantibodies do not have the potential to serve as a prognostic tool for disease severity in patients with MS. Since MS patients with positive serum AABS did not significantly more often suffer from clinical manifest AIs than MS patients with negative serum AABS, the role of routine testing of serum AABS in MS patients should be critically called into question.This article is protected by copyright. All rights reserved.

https://www.onlinelibrary.wiley.com/doi/abs/10.1111/ane.13054?af=R

Source: Acta Neurologica Scandinavica - November 17, 2018 Category: Neurology Authors: Assunta Dal ‐Bianco, Fritz Wenhoda, PS Rommer, Michael Weber, Patrick Altmann, Jörg Kraus, Fritz Leutmezer, Sabine Salhofer‐Polanyi Tags: Original Article Source Type: research